REHOVOT, Israel (AP) _ Foamix Pharmaceuticals Ltd. (FOMX) on Tuesday reported a loss of $15.2 million in its first quarter.
The Rehovot, Israel-based company said it had a loss of 28 cents per share.
The acne treatment developer posted revenue of $308,000 in the period.
In the final minutes of trading on Tuesday, the company's shares hit $3.15. A year ago, they were trading at $5.06.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FOMX at https://www.zacks.com/ap/FOMX